Simulator firm races ahead with Cadillac F1 agreement
A tech firm is in pole position after securing an elite motorsport deal.
Dynisma is set to supply a driving simulator to the Cadillac Formula 1 team.
The Bristol-based company says the technology will support vehicle development, driver preparation and set-up work across the global single-seater competition’s calendar.
It adds the simulator will be installed at Cadillac Formula 1’s Indianapolis site, where it will operate as a “key investment” in the nascent team’s “long-term performance capability”.
Ash Warne, Dynisma founder and chief technology officer, said: “We are proud to support Cadillac Formula 1 as it continues to build its technical capability.
“Our technology is engineered to deliver a highly repeatable, high-fidelity environment, supporting informed decision-making across long-term car development and race-by-race set-up preparation.”
Nick Chester, Cadillac Formula 1 chief technical officer, added: “Selecting the right simulator platform is a key decision for any team.
“This is an important step as we establish tools and systems to support our engineering work and driver programme over coming seasons.”
Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →
Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.
Construction must be built on commercial discipline
Devolution needs financial firepower to drive growth
The value of creating a stronger careers route
Apprenticeships: Invest in talent or keep chasing it
Are you ready for salary transparency?
Confidence the key to our artificial intelligence future
The missing piece of the puzzle in the NEET crisis
The North East investment story needs two engines
We must forge change to close the skills gap
Creating the conditions for North East talent to thrive
Time to end London monopoly on arts talent
Why local government is key to devolution success